Leerink Partnrs cut shares of Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) from a strong-buy rating to a hold rating in a report released on Tuesday morning, Zacks.com reports. Several other equities research analysts have also recently commented on the company. StockNews.com raised Regeneron Pharmaceuticals from a buy rating to a strong-buy rating in a research […]

Cantor Fitzgerald restated their overweight rating on shares of Biohaven (NYSE:BHVN – Free Report) in a research report sent to investors on Tuesday morning, Benzinga reports. Other research analysts also recently issued research reports about the company. HC Wainwright restated a buy rating and issued a $59.00 price objective on shares of Biohaven in a […]

Biohaven (NYSE:BHVN – Free Report) had its price target upped by Bank of America from $52.00 to $62.00 in a research report report published on Tuesday, Benzinga reports. Bank of America currently has a buy rating on the stock. Several other brokerages also recently weighed in on BHVN. Morgan Stanley assumed coverage on Biohaven in […]

StockNews.com downgraded shares of M&T Bank (NYSE:MTB – Free Report) from a hold rating to a sell rating in a report issued on Tuesday. Other research analysts have also recently issued research reports about the stock. Royal Bank of Canada upped their price target on shares of M&T Bank from $160.00 to $174.00 and gave […]

Lamb Weston (NYSE:LW – Free Report) had its price objective increased by Citigroup from $72.00 to $75.00 in a research note published on Monday, Benzinga reports. Citigroup currently has a buy rating on the specialty retailer’s stock. LW has been the topic of a number of other research reports. The Goldman Sachs Group decreased their […]

Robert W. Baird initiated coverage on shares of ResMed (NYSE:RMD – Free Report) in a report released on Tuesday morning, MarketBeat.com reports. The firm issued an outperform rating and a $280.00 target price on the medical equipment provider’s stock. A number of other equities analysts have also recently commented on the stock. Wolfe Research reiterated […]

HC Wainwright restated their buy rating on shares of Biohaven (NYSE:BHVN – Free Report) in a research note released on Tuesday morning, Benzinga reports. The firm currently has a $59.00 price objective on the stock. Several other analysts have also weighed in on BHVN. Piper Sandler upped their target price on Biohaven from $66.00 to […]

Royal Bank of Canada reaffirmed their outperform rating on shares of IDEAYA Biosciences (NASDAQ:IDYA – Free Report) in a research report report published on Tuesday morning, Benzinga reports. Royal Bank of Canada currently has a $61.00 price objective on the stock. Several other equities research analysts have also recently weighed in on the company. Citigroup […]

Bank of America downgraded shares of Leonardo DRS (NASDAQ:DRS – Free Report) from a buy rating to a neutral rating in a report released on Tuesday morning, Marketbeat reports. Bank of America currently has $30.00 price objective on the stock, up from their prior price objective of $26.00. Several other equities research analysts have also […]

Cantor Fitzgerald restated their overweight rating on shares of Marinus Pharmaceuticals (NASDAQ:MRNS – Free Report) in a report released on Tuesday morning, Benzinga reports. Cantor Fitzgerald currently has a $13.00 target price on the biopharmaceutical company’s stock. Several other equities analysts have also recently issued reports on the company. StockNews.com raised Marinus Pharmaceuticals from a […]

Leerink Partners reaffirmed their market perform rating on shares of Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) in a report published on Tuesday morning, Marketbeat Ratings reports. The brokerage currently has a $1,077.00 target price on the biopharmaceutical company’s stock, down from their prior target price of $1,175.00. REGN has been the subject of a number […]

StockNews.com lowered shares of QuinStreet (NASDAQ:QNST – Free Report) from a hold rating to a sell rating in a research note published on Monday morning. A number of other equities analysts have also recently issued reports on QNST. Barrington Research restated an outperform rating and issued a $22.00 price objective on shares of QuinStreet in […]

BMO Capital Markets reiterated their outperform rating on shares of Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) in a research report released on Tuesday morning, Benzinga reports. They currently have a $1,300.00 price objective on the biopharmaceutical company’s stock. Several other analysts have also weighed in on REGN. TD Cowen upped their price objective on Regeneron […]

Biohaven (NYSE:BHVN – Free Report) had its target price increased by Robert W. Baird from $58.00 to $60.00 in a report published on Monday morning, Benzinga reports. They currently have an outperform rating on the stock. Several other research analysts have also recently weighed in on the company. HC Wainwright restated a buy rating and […]

Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) was downgraded by research analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a note issued to investors on Wednesday. Other research analysts have also issued reports about the company. Morgan Stanley dropped their price target on Regeneron Pharmaceuticals from $1,183.00 to $1,182.00 and set […]

UnitedHealth Group (NYSE:UNH – Get Free Report) was downgraded by research analysts at StockNews.com from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Wednesday. Several other equities analysts also recently commented on UNH. Baird R W upgraded shares of UnitedHealth Group to a “strong-buy” rating in […]